NCT02324062 2026-02-18
HCP
University of Southern California
Completed
Clinical Trials
28 trialsNCT05247853 2025-10-16
HPV Vaccine Effectiveness Study in Rwandan Women Living With HIV
Montefiore Medical Center
Completed
NCT06263582 2025-08-19
Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya
UNC Lineberger Comprehensive Cancer Center
Phase 1 Completed
NCT04766502 2025-07-24
PIPADN
Institut de Cancérologie de Lorraine
Phase NA Completed
NCT04770090 2025-07-10
CTC-COL
University Hospital, Montpellier
Phase NA Completed
NCT02662621 2025-06-05
EXODIAG
Centre Georges Francois Leclerc
Phase NA Completed
NCT03749720 2025-04-01
HPV in Blood Samples From Cervical Cancer Patients.
University of Aarhus
Phase NA Completed
NCT04697264 2025-03-30
Adipocytokines in Endometrial Cancer
University of Surrey
Completed
NCT03510689 2024-10-16
Gene-HEART
Abramson Cancer Center at Penn Medicine
Completed
NCT01350908 2024-01-31
Study of Circulating Tumoral DNA in Ovarian Cancer
Institut Curie
Phase NA Completed
NCT04021459 2023-10-03
E-CTC
University Hospital, Montpellier
Phase NA Completed
NCT02781272 2023-06-05
EMBER
Angle plc
Completed
NCT02973750 2023-01-26
Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer
H. Lee Moffitt Cancer Center and Research Institute
Completed
NCT02428842 2023-01-20
BIO-RAIDs
Institut Curie
Phase NA Completed
NCT02952521 2022-05-10
Ovarian Tumor Biopsies to Study Response to Treatments
University Health Network, Toronto
Completed
NCT04154163 2022-02-28
ADOPT
University of Dundee
Completed
NCT04905576 2021-05-27
Quality of Life Interventions During Cervical Cancer Treatment
University of Iowa
Phase NA Completed
NCT03355820 2020-11-19
A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study
GlaxoSmithKline
Phase 3 Completed
NCT00947115 2020-10-30
Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects
GlaxoSmithKline
Phase 3 Completed
NCT01546363 2020-10-05
Tissue and Plasma Biomarkers of Lymph Node Involvement in Cervical Cancer
Stanford University
Completed
NCT00877877 2020-01-18
Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.
GlaxoSmithKline
Phase 3 Completed
NCT04014426 2019-07-10
PIPAC-Secure
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Completed
NCT02785731 2018-11-09
Evaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass.
Angle plc
Completed
NCT00929526 2016-10-20
Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study
GlaxoSmithKline
Phase 3 Completed
NCT01391351 2016-07-21
miRSa
Centre Francois Baclesse
Phase NA Completed
NCT02016833 2015-04-30
Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity
PX Biosolutions
Completed
NCT01333748 2012-07-13
EXSAL
Centre Francois Baclesse
Phase 2 Completed
NCT00436189 2008-04-30
Assess Cancer in Ovarian Tumors With Biomarkers.
Ciphergen Biosystems
Phase NA Completed